About YERVOY
YERVOY is a company based in Princeton (United States) founded in 2009. It operates as a B2B. YERVOY operates in a competitive market with competitors including iMedX, Centivo, Omega Healthcare, Rennova Health and Light Wave Dental, among others.
- Headquarter Princeton, United States
- SectorsHealthcare
- Website yervoy.com
Competitors of YERVOY
YERVOY operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iMedX, Centivo, Omega Healthcare, Rennova Health and Light Wave Dental, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imedx.com | 2002 | Atlanta, United States | $22.28M | 951 | Revenue cycle management platform is provided to healthcare providers. | |
| centivo.com | 2017 | New York, United States | $224M | 212 | Provider of self funded health plan | |
| omegahms.com | 2003 | Boca Raton, United States | – | 26,750 | Healthcare outsourcing services are provided to various sectors. | |
| rennovahealth.com | 1989 | West Palm Beach, United States | $8.59M | – | Software solutions for laboratory diagnostics are provided to healthcare. | |
| lightwavedental.com | 2010 | Woodbridge, United States | $20.24M | 1,847 | Dental practice brokerage services are provided to facilitate transactions. | |
| multiplan.us | 1980 | New York, United States | – | 2,800 | Medical payment integrity and analytics services are provided by MultiPlan. | |
| accesshealthcare.com | 2011 | Chennai, India | $3.9M | 17,868 | Provider of revenue cycle management, BPO, IT, and finance and accounting services | |
| vmghealth.com | 1995 | Dallas, United States | – | 176 | Healthcare transaction advisory services are provided by VMG Health. | |
| rmsweb.com | 2006 | Oklahoma, United States | $12.75M | 115 | Automated revenue cycle management and data analytics services are provided. | |
| conveyhealthsolutions.com | 2001 | Sunrise, United States | – | – | Healthcare technology and outsourcing solutions are provided for health plans. |
Detailed competitors of YERVOY
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of YERVOY
Websites that share an audience with YERVOY (yervoy.com).
Websites whose visitors overlap most with YERVOY. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| proleukin.com | 96% | 1.2K | #8,599,991 | View details |
Latest news on Yervoy
Complete news archive for YERVOY
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to YERVOY
10 companies that operate in the same segment as YERVOY (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about YERVOY
YERVOY was founded in 2009.
YERVOY is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
YERVOY operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, oncology, and immunotherapy. A prescription medicine to prevent melanoma recurrence after treatment. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
YERVOY's top competitors include Centivo, Access Healthcare and Rennova Health.